Content about Antacid

August 17, 2012
Generics contend in PPIs

Procter & Gamble’s Prilosec OTC still is the best-selling antacid on the market, with more than $252.7 million in annual sales for the 52 weeks ended July 8 across food, drug and mass (excluding Walmart), followed by fellow proton-pump inhibitor Novartis’ Prevacid 24HR ($104.1 million).


February 9, 2012
FDA issues warning on PPI, H2 blocker antacids: May increase risk of CDAD

The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

December 2, 2011
Axia3 launches Axia3 ProDigestive antacid

Axia3 on Thursday announced the launch of its Axia3 ProDigestive antacid as a new dietary supplement that delivers relief from occasional heartburn, with a proprietary blend of potent ProDigestive enzymes to help promote healthy digestion.

October 11, 2011
Antacids expect some upset

Sales of antacid tablets are up almost 3%. And while nobody is suggesting that upward trajectory is going to change anytime soon, there will be a decent amount of volatility in the coming year.


July 25, 2011
Wellness drives sales in digestives, probiotics

Sales in the digestives aisle going forward look positive, especially as an aging population begins paying closer attention to healthy diets, including the right amount of dietary fiber to keep things “regular” and supplementation with probiotics for overall digestive health. 


March 4, 2011
PPIs time out to Tums

NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.

December 7, 2010
P&G, GSK hold their own 
in crowded antacid aisle

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


February 17, 2010
Novartis to change name, repackage Maalox Total Relief

Choosing the wrong liquid Maalox product can have harmful consequences, the Food and Drug Administration...

© 2013 Drug Store News. All Rights Reserved.